Prognostic Value of Immune-Inflammatory Index in PSI IV-V Patients with COVID-19.
Rui HanHonghui SuGangwen GuoQiao WangJiahui MaZhenxing LiShitong HuangYuncheng NiRong HuDong HuangHaocheng ZhouPublished in: BioMed research international (2021)
Procalcitonin and neutrophil-to-lymphocyte ratio may potentially be effective predictors for mortality in PSI IV-V patients with COVID-19. Increased procalcitonin and neutrophil-to-lymphocyte ratio were associated with greater risk of mortality.